Current role
Christopher Haqq
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Elicio Therapeutics, Inc. (ELTX)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Elicio Therapeutics, Inc. (ELTX) | M.D., Ph.D., Executive Vice President, Head of Research and Development and Chief Medical Officer | $507,807 | $926,452 |
| 2023 | Elicio Therapeutics, Inc. (ELTX) | M.D., Ph.D., Executive Vice President, Head of Research and Development and Chief Medical Officer | $488,276 | $673,821 |
| 2022 | Elicio Therapeutics, Inc. (ELTX) | M.D., Ph.D., Executive Vice President, Head of Research and Development and Chief Medical Officer | $465,025 | $1,162,356 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.